OKYO Pharma Limited
OKYO Pharma Limited (OKYO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OKYO · as of Jun 9, 2026
Key Statistics
Explore OKYO Pharma Limited Data
okyo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The OKYO analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $7.00, representing +340.25% upside from the current price of $1.59.
Competitors & Peers
okyo competitorsOKYO
ANEB
CLNN
COYA
IMMX
MGNXStock Performance
Full HistoryAbout OKYO Pharma Limited
OKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for individuals in the United Kingdom experiencing inflammatory eye co…
what is okyo pharma limited · okyo stock overview · okyo pharma limited company profile · who is okyo pharma limited ceo · okyo NASDAQ · okyo pharma limited headquarters · okyo pharma limited business segments
About Stock Overview & Key Data
OKYO Pharma Limited (OKYO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 17, 2022. As of the latest trading session, OKYO stock price is $1.59, with a market capitalization of $61.0M. The stock has returned -24.29% over the past 12 months and -23.19% year-to-date.
According to 2 Wall Street analysts, the consensus rating for OKYO Pharma Limited stock is Buy, with an average 12-month price target of $7.00. In fiscal year 2025, OKYO Pharma Limited reported revenue of — and net income of -$4.7M. For detailed data — including OKYO Pharma Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, OKYO Pharma Limited (OKYO) stock price is $1.59. The stock is traded on NASDAQ under the ticker symbol OKYO. The 52-week range is $1.44 – $3.35.